Cooper Financial Group’s Revolution Medicines RVMD Stock Holding History

Cooper Financial Group’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$369K	Buy	+1,800	New	+$357K	0.03%	305

Other funds holding RVMD

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Colton Groome Financial Advisors Asheville, North Carolina $427M AUM 13.21% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

RVW Wealth Los Angeles, California $1.56B AUM 16.49% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Burkett Financial Services Rock Hill, South Carolina $331M AUM 14.93% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

Cooper Financial Group's RVMD Position: Q3 2026 in Review

Cooper Financial Group opened a new position in Revolution Medicines (RVMD) in Q3 2026: 1,800 shares worth $369K. The stake represents 0.03% of the portfolio and ranks #305 among its holdings.

17 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

Cooper Financial Group held 1,800 shares of Revolution Medicines worth $369K as of Q3 2026.
Revolution Medicines was a new Cooper Financial Group position in Q3 2026.
Revolution Medicines made up 0.03% of Cooper Financial Group's portfolio in Q3 2026, its #305 holding.
17 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Cooper Financial Group's 13F filing for Q3 2026, filed 7 Oct 2026.